Feb 15, 2018
Free Research Reports on These Drug Makers Stocks -- Impax Labs, Merck, Novartis, and Pfizer
Feb 06, 2018
Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations
Feb 05, 2018
Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta®
Feb 01, 2018
Amneal Introduces Isotretinoin Capsules, USP
Jan 30, 2018
CorePharma, LLC Acquired by Investor Group
Jan 16, 2018
Impax to Report Fourth Quarter and Full Year 2017 Results on March 1, 2018
Jan 03, 2018
Amneal Pharmaceuticals and Impax Laboratories to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 29, 2017
Quotidian Technical Highlights on Selected Drug Makers Stocks -- TherapeuticsMD, Impax Laboratories, GlaxoSmithKline, and AstraZeneca
Dec 19, 2017
Impax Announces Sale of Taiwan Manufacturing Facility
Dec 18, 2017
Robert Stewart to Join Amneal Pharmaceuticals as President
Dec 08, 2017
Impax Receives Tentative FDA Approval of Generic Coreg CR® (Carvedilol Phosphate) Extended-Release Capsules
Nov 13, 2017
Technical Snapshots for These Drug Makers Stocks -- AstraZeneca, Impax Laboratories, TherapeuticsMD, and GlaxoSmithKline
Nov 09, 2017
Impax Reports Third Quarter 2017 Results
Nov 08, 2017
Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly
Nov 06, 2017
Impax Announces Successful Completion of Consent Solicitation with Respect to its 2.00% Convertible Senior Notes due 2022
Oct 24, 2017
Amerigen and Biophore Collaborate on Penicillamine Generics
Oct 23, 2017
Impax Announces FDA Approval and Launch of Generic Renvela® (Sevelamer Carbonate) Tablets, 800 mg
Oct 17, 2017
Amneal And Impax To Combine
Oct 03, 2017
Impax to Report Third Quarter 2017 Results on November 9, 2017
Oct 03, 2017
Drug Makers Stocks on Investors' Radar -- Impax Laboratories, GlaxoSmithKline, Novartis, and TherapeuticsMD